Valganciclovir
Top View
- Product Information for Valganciclovir
- Successful Treatment with Oral Valganciclovir in Immunocompetent Infant with Gastrointestinal Manifestations of Cytomegalovirus Infection
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Renal Dosage Adjustment Guidelines for Antimicrobials the Pharmacists Will Automatically Adjust the Doses of Any of the Antimicr
- AIDS Related Treatments
- WHO Model List of Essential Medicines
- Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring
- SYMTUZA® (Darunavir, Cobicistat, Emtricitabine, and Tenofovir
- ANTIRETROVIRAL CONTRAINDICATIONS and DRUG INTERACTIONS (Part of 5)
- NDA 21-356/S-011 Page 4 VIREAD (Tenofovir Disoproxil Fumarate)
- Viral Infections
- Study Protocol: Amendment 1
- Valganciclovir Cipla 450 Mg Film-Coated Tablets
- ODEFSEY (Emtricitabine, Rilpivirine, and Tenofovir
- VALCYTE Prescribing Information
- Medication Guidelines for Solid Organ Transplants
- Approved Antiviral Drugs Over the Past 50 Years
- Package Leaflet: Information for the User Valganciclovir Aurobindo 450